Purchases and Sales Made in Q2 2023 in Aldeyra Therapeutics, Inc. (ALDX)
This table provides information about the institutional ownership of Aldeyra Therapeutics, Inc. (ALDX) during Q2 2023. The information is specifically focused on institutions that hold shares of Aldeyra Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-635K- 40.57% |
$4.51M - $7.55M
|
930K
$4.55M
|
|
|
Aug 09, 2023
Q2 2023
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-785K- 42.6% |
$5.58M - $9.34M
|
1.06M
$5.18M
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-857K- 77.99% |
$6.09M - $10.2M
|
242K
$1.18M
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-859K- 72.79% |
$6.11M - $10.2M
|
321K
$1.57M
|